| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:528742145:2617 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:528742145:2617?format=raw |
LEADER: 02617cam a2200421 a 4500
001 011575407-5
005 20090417052333.0
008 080305s2008 mau b 001 0 eng
010 $a 2008010541
020 $a9780980209440 (hardcover : alk. paper)
020 $a0980209447 (hardcover : alk. paper)
035 0 $aocn213379632
040 $aDLC$cDLC$dDLC
043 $an-us---
050 00 $aHD9665.5$b.I55 2008
060 00 $a2008 J-828
060 10 $aQV 736$bI584 2008
082 00 $a338.4/791510973$222
245 00 $aInnovation and the pharmaceutical industry :$bcritical reflections on the virtues of profit /$cedited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.
260 $aSalem, MA :$bM & M Scrivener Press,$cc2008.
300 $aviii, 245 p. ;$c24 cm.
490 1 $aTrends and conflicts
504 $aIncludes bibliographical references and index.
505 0 $aPharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies and their obligations to developing countries : psychopaths or scapegoats? / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Why America does not have a second drug problem / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.
650 0 $aMedical policy$zUnited States.
650 0 $aPharmaceutical industry.
650 0 $aDrug development.
650 0 $aMedical innovations.
650 22 $aDrug Industry$xeconomics$zUnited States.
650 22 $aDrug Industry$xethics$zUnited States.
650 0 $aPharmaceutical Preparations$xeconomics$zUnited States.
650 22 $aHealth Policy$zUnited States.
650 22 $aPharmaceutical Preparations$xeconomics$zUnited States.
700 1 $aEngelhardt, H. Tristram$q(Hugo Tristram),$d1941-
700 1 $aGarrett, Jeremy R.
830 0 $aConflicts and trends.
988 $a20080927
906 $0DLC